Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 27


Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.

Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman SM.

Cancer Prev Res (Phila). 2010 Dec;3(12):1523-33. doi: 10.1158/1940-6207.CAPR-09-0256.


Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.

Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM.

Am J Epidemiol. 2010 Sep 1;172(5):566-77. doi: 10.1093/aje/kwq148. Epub 2010 Aug 6.


Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk.

Beilby J, Ambrosini GL, Rossi E, de Klerk NH, Musk AW.

Eur J Clin Nutr. 2010 Oct;64(10):1235-8. doi: 10.1038/ejcn.2010.124. Epub 2010 Aug 4.


Fruits and vegetables in relation to prostate cancer in Japanese men: the Japan Public Health Center-Based Prospective Study.

Takachi R, Inoue M, Sawada N, Iwasaki M, Sasazuki S, Ishihara J, Tsubono Y, Tsugane S; Japan Public Health Center-Based Prospective Study Group.

Nutr Cancer. 2010;62(1):30-9. doi: 10.1080/01635580903191502.


Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study.

Karppi J, Kurl S, Nurmi T, Rissanen TH, Pukkala E, Nyyssönen K.

Ann Epidemiol. 2009 Jul;19(7):512-8. doi: 10.1016/j.annepidem.2009.03.017. Epub 2009 May 13.


Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort.

Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN.

Cancer Causes Control. 2009 Sep;20(7):1161-71. doi: 10.1007/s10552-009-9304-4. Epub 2009 Feb 11.


Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.

Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L, Tjønneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, Psaltopoulou T, Trichopoulou A, Trichopoulos D, Palli D, Vineis P, Tumino R, Berrino F, Kiemeney L, Bueno-de-Mesquita HB, Quirós JR, González CA, Martinez C, Larrañaga N, Chirlaque MD, Ardanaz E, Stattin P, Hallmans G, Khaw KT, Bingham S, Slimani N, Ferrari P, Rinaldi S, Riboli E.

Am J Clin Nutr. 2007 Sep;86(3):672-81.


The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer.

Kavanaugh CJ, Trumbo PR, Ellwood KC.

J Natl Cancer Inst. 2007 Jul 18;99(14):1074-85. Epub 2007 Jul 10. Review.


Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk?

Giovannucci E.

J Natl Cancer Inst. 2007 Jul 18;99(14):1060-2. Epub 2007 Jul 10. No abstract available.


Fruit, vegetable, vitamin A intakes, and prostate cancer risk.

Ambrosini GL, de Klerk NH, Fritschi L, Mackerras D, Musk B.

Prostate Cancer Prostatic Dis. 2008;11(1):61-6. Epub 2007 May 22.


Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.

Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):962-8.


Risk factors for prostate cancer incidence and progression in the health professionals follow-up study.

Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC.

Int J Cancer. 2007 Oct 1;121(7):1571-8.


Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.

Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Parnes HL, Lippman SM, Coltman CA Jr.

J Urol. 2007 May;177(5):1749-52.


Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States).

Stram DO, Hankin JH, Wilkens LR, Park S, Henderson BE, Nomura AM, Pike MC, Kolonel LN.

Cancer Causes Control. 2006 Nov;17(9):1193-207.


Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA Jr.

J Natl Cancer Inst. 2006 Aug 16;98(16):1128-33.


A prospective study of lycopene and tomato product intake and risk of prostate cancer.

Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):92-8.


Is it time to abandon the food frequency questionnaire?

Kristal AR, Peters U, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2826-8. No abstract available.


The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.

Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR.

J Clin Oncol. 2004 Jun 1;22(11):2141-9.


Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study.

Wu K, Erdman JW Jr, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):260-9.


The influence of finasteride on the development of prostate cancer.

Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr.

N Engl J Med. 2003 Jul 17;349(3):215-24. Epub 2003 Jun 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk